200,000+ products from a single source!
sales@angenechem.com
30651-60-6 | 1-Piperazinamine
CAS No: 30651-60-6 Catalog No: AG0030RP MDL No:MFCD00082807
Product Description
Catalog Number:
AG0030RP
Chemical Name:
1-Piperazinamine
CAS Number:
30651-60-6
Molecular Formula:
C4H11N3
Molecular Weight:
101.1502
MDL Number:
MFCD00082807
IUPAC Name:
piperazin-1-amine
InChI:
InChI=1S/C4H11N3/c5-7-3-1-6-2-4-7/h6H,1-5H2
InChI Key:
IYPZRUYMFDWKSS-UHFFFAOYSA-N
SMILES:
NN1CCNCC1
Properties
Complexity:
48.9
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
101.095g/mol
Formal Charge:
0
Heavy Atom Count:
7
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
101.153g/mol
Monoisotopic Mass:
101.095g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
41.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.1
Literature
| Title | Journal |
|---|---|
| Metabolism, excretion, and pharmacokinetics of ((3,3-difluoropyrrolidin-1-yl)((2S,4S)-4-(4-(pyrimidin-2-yl)piperazin-1-yl)pyrrolidin-2-yl)methanone, a dipeptidyl peptidase inhibitor, in rat, dog and human. | Drug metabolism and disposition: the biological fate of chemicals 20121101 |
| Evaluation of (99m)Tc(i)-tricarbonyl complexes of fluoroquinolones for targeting bacterial infection. | Metallomics : integrated biometal science 20121101 |
| Studies on the antimicrobial properties of N-acylated ciprofloxacins. | Bioorganic & medicinal chemistry letters 20121015 |
| Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. | Journal of medicinal chemistry 20120510 |
| Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors. | Journal of medicinal chemistry 20120112 |
| Redox-controlled interconversion between trigonal prismatic and octahedral geometries in a monodithiolene tetracarbonyl complex of tungsten. | Inorganic chemistry 20120102 |
| Simultaneous determination of a novel diphenylpiperazine calcium channel blocker and its four metabolites in rat liver microsomes by liquid chromatography tandem mass spectrometry. | Pharmacology 20120101 |
| Piperazine-1,4-diium bis-(pyridine-2,6-dicarboxyl-ato-κO,N,O)cobaltate(II) tetra-hydrate. | Acta crystallographica. Section E, Structure reports online 20110701 |
| Design, synthesis, and structure-activity relationship exploration of 1-substituted 4-aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one analogues as inhibitors of the annexin A2-S100A10 protein interaction. | Journal of medicinal chemistry 20110414 |
| Prevalence of aac(6')-Ib-cr plasmid-mediated and chromosome-encoded fluoroquinolone resistance in Enterobacteriaceae in Italy. | Gut pathogens 20110101 |
| Tetra-imidazolium piperazinediium bis-(benzene-1,3,5-tricarboxyl-ate) dihydrate. | Acta crystallographica. Section E, Structure reports online 20101101 |
| Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor. | Bioorganic & medicinal chemistry letters 20100915 |
| (3R,8aS)-3-Ethyl-perhydro-pyrrolo[1,2-a]pyrazine-1,4-dione. | Acta crystallographica. Section E, Structure reports online 20100201 |
| Redetermination of 2-[4-(2-hydroxy-ethyl)piperazin-1-ium-1-yl]ethanesul-fonate at 100 K. | Acta crystallographica. Section E, Structure reports online 20091201 |
| Quinolones: action and resistance updated. | Current topics in medicinal chemistry 20090801 |
| Triprotic acid-base microequilibria and pharmacokinetic sequelae of cetirizine. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090628 |
| Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships. | Journal of medicinal chemistry 20090611 |
| Robust self-assembled monolayers of Ru(II) and Os(II) polypyridines on gold surfaces: exploring new potentials. | Chemistry (Weinheim an der Bergstrasse, Germany) 20090602 |
| Direct intramolecular gas-phase transfer reactions during fragmentation of sildenafil and thiosildenafil analogs in electrospray ionization mass spectrometry. | Rapid communications in mass spectrometry : RCM 20090301 |
| Isolation and identification of hydroxythiohomosildenafil in herbal dietary supplements sold as sexual performance enhancement products. | Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20090201 |
| Anthracycline extravasation injuries: management with dexrazoxane. | Therapeutics and clinical risk management 20090101 |
| Novel fluorescent pH sensor based on coumarin with piperazine and imidazole substituents. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20081201 |
| catena-Poly[[[(dimethyl-malonato-κO:O')(perchlorato-κO)copper(II)]-μ-bis-(3-pyridylmeth-yl)piperazinediium-κN:N] perchlorate dihydrate]. | Acta crystallographica. Section E, Structure reports online 20081201 |
| 8-Chloro-5-(4-phenethylpiperazin-1--yl)pyrido[2,3-b][1,5]benzoxazepine. | Acta crystallographica. Section E, Structure reports online 20081001 |
| Isolation and identification of thiohomosildenafil and thiosildenafil in health supplements. | Journal of pharmaceutical and biomedical analysis 20080609 |
| Synthesis and biological characterization of novel 2-quinolinecarboxamide ligands of the peripheral benzodiazepine receptors bearing technetium-99m or rhenium. | Bioconjugate chemistry 20080601 |
| Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery. | The AAPS journal 20080301 |
| Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation. | Drug metabolism and disposition: the biological fate of chemicals 20070601 |
| 4-Amino derivatives of the Hsp90 inhibitor CCT018159. | Bioorganic & medicinal chemistry letters 20060501 |
| Solid-phase S-3CR generates N-substituted alpha-aminonitriles for the synthesis of alpha-phenyl-alpha-(1-piperazinyl) substituted amino acids. | Amino acids 20060501 |
| Enhanced FTase activity achieved via piperazine interaction with catalytic zinc. | Bioorganic & medicinal chemistry letters 20060215 |
| Solution and solid state 13C NMR and X-ray studies of genistein complexes with amines. Potential biological function of the C-7, C-5, and C4'-OH groups. | Organic & biomolecular chemistry 20031021 |
| Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors. | Bioorganic & medicinal chemistry letters 20031006 |
| Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor. | Journal of medicinal chemistry 20030410 |
| Functional group interactions of a 5-HT3R antagonist. | BMC biochemistry 20020101 |
| Application of LC-MS analysis to the characterisation of the in vitro and in vivo metabolite profiles of RGH-1756 in the rat. | Journal of pharmaceutical and biomedical analysis 20010301 |
| Synthesis and stereoselective kappa-receptor binding of methylated analogues of GR-89.696. | European journal of medicinal chemistry 20010201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.